Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)
102.59
+1.84 (1.83%)
At close: Mar 6, 2026
SHA:688198 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 56.01 | 295.31 | 128.3 | 156.78 |
Short-Term Investments | - | 135.87 | 133.32 | - | - |
Trading Asset Securities | - | 178.16 | 107 | 484.61 | 615.53 |
Cash & Short-Term Investments | 337.35 | 370.04 | 535.62 | 612.91 | 772.31 |
Cash Growth | -8.83% | -30.91% | -12.61% | -20.64% | 1.36% |
Accounts Receivable | - | 133.44 | 86 | 59.61 | 40.39 |
Other Receivables | - | 4.77 | 3.14 | 1.98 | 0.74 |
Receivables | - | 138.21 | 89.14 | 61.59 | 41.13 |
Inventory | - | 52.74 | 34.9 | 31.49 | 21.96 |
Prepaid Expenses | - | - | 1.6 | - | 0.28 |
Other Current Assets | - | 29.82 | 17.96 | 18.39 | 17.51 |
Total Current Assets | - | 590.81 | 679.22 | 724.37 | 853.19 |
Property, Plant & Equipment | - | 433.74 | 278.28 | 192.09 | 89.85 |
Long-Term Investments | - | 122.92 | 182.48 | 170.63 | 6.07 |
Goodwill | - | 17.27 | 17.01 | - | - |
Other Intangible Assets | - | 112.18 | 92.76 | 44.96 | 43.16 |
Long-Term Deferred Tax Assets | - | 14.81 | 24.16 | 28.64 | 34.49 |
Long-Term Deferred Charges | - | 18.88 | 0.93 | 1.46 | 1.99 |
Other Long-Term Assets | - | 120.24 | 52.17 | 17.77 | 2.2 |
Total Assets | - | 1,431 | 1,327 | 1,180 | 1,031 |
Accounts Payable | - | 1.2 | 1.19 | 0.43 | 0.76 |
Accrued Expenses | - | 50.98 | 29.79 | 24.83 | 17.05 |
Current Portion of Leases | - | 3.45 | 3.27 | 0.84 | 0.94 |
Current Income Taxes Payable | - | 0.96 | - | 0.17 | - |
Current Unearned Revenue | - | 1.32 | 0.46 | 0.43 | 0.62 |
Other Current Liabilities | - | 56.38 | 45.88 | 36.56 | 17.24 |
Total Current Liabilities | - | 114.28 | 80.58 | 63.26 | 36.6 |
Long-Term Leases | - | 6.33 | 9.02 | 0.56 | 0.72 |
Long-Term Unearned Revenue | - | 33.23 | 33.46 | 11.72 | 0.2 |
Long-Term Deferred Tax Liabilities | - | 13.01 | 12.39 | 1.19 | 0.16 |
Other Long-Term Liabilities | - | 13.41 | 3.01 | 3.76 | 5.05 |
Total Liabilities | - | 180.28 | 138.47 | 80.49 | 42.73 |
Common Stock | - | 137.4 | 136.58 | 135.67 | 96.44 |
Additional Paid-In Capital | - | 823.05 | 803.27 | 759.67 | 733.85 |
Retained Earnings | - | 290.47 | 253.4 | 206.03 | 159.16 |
Comprehensive Income & Other | - | 1.68 | 1.36 | 0.07 | 0.06 |
Total Common Equity | 1,246 | 1,253 | 1,195 | 1,101 | 989.51 |
Minority Interest | - | -2.03 | -6.06 | -2.02 | -1.28 |
Shareholders' Equity | 1,234 | 1,251 | 1,189 | 1,099 | 988.23 |
Total Liabilities & Equity | - | 1,431 | 1,327 | 1,180 | 1,031 |
Total Debt | 87.41 | 9.79 | 12.29 | 1.4 | 1.66 |
Net Cash (Debt) | 249.94 | 360.26 | 523.33 | 611.51 | 770.65 |
Net Cash Growth | -30.62% | -31.16% | -14.42% | -20.65% | 1.15% |
Net Cash Per Share | 1.82 | 2.63 | 3.82 | 4.50 | 5.72 |
Filing Date Shares Outstanding | 133.41 | 137.4 | 136.58 | 135.67 | 135.01 |
Total Common Shares Outstanding | 137.75 | 137.4 | 136.58 | 135.67 | 135.01 |
Working Capital | - | 476.52 | 598.64 | 661.12 | 816.59 |
Book Value Per Share | 9.04 | 9.12 | 8.75 | 8.12 | 7.33 |
Tangible Book Value | 1,064 | 1,123 | 1,085 | 1,056 | 946.35 |
Tangible Book Value Per Share | 7.72 | 8.17 | 7.94 | 7.79 | 7.01 |
Buildings | - | 254.99 | 42.88 | 42.88 | 42.88 |
Machinery | - | 135.92 | 75.28 | 41.32 | 28.71 |
Construction In Progress | - | 87.67 | 190.24 | 141.15 | 47 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.